About Coyote Bioscience Co., Ltd.
Coyote Bioscience Co., Ltd. is a Chinese biotechnology company founded in 2009, with its headquarters and R&D centre in Beijing, specialising in point-of-care (POCT) molecular diagnostics. Its official website has an English version, from which this listing was corroborated, and its motto — molecular diagnostics for everyone — sums up its aim of taking PCR out of the central laboratory, with GMP production in Jiangsu and factories and testing laboratories in Beijing and Tianjin.
Its signature technology is one-step direct PCR, protected by the international Molecular In-Parallel Reaction patent, which removes the need for prior nucleic acid extraction. On it the company has built the portable Mini8 real-time PCR system — once included in the WHO Emergency Quality Assurance Mechanism for Ebola testing — the FlashDetect rapid testing line and the fully automated Flash10, Robo and Nano molecular robot family, as well as digital PCR platforms, holding around 95 patents according to industry sources.
Its applications cover infectious diseases, personalised medicine and cancer screening, with solutions deployable in hospitals, disease control centres and low-resource settings. For distributors of rapid molecular diagnostics, Coyote offers a Chinese manufacturer with its own direct PCR technology and a complete chain of R&D, production, sales and testing services.
Its signature technology is one-step direct PCR, protected by the international Molecular In-Parallel Reaction patent, which removes the need for prior nucleic acid extraction. On it the company has built the portable Mini8 real-time PCR system — once included in the WHO Emergency Quality Assurance Mechanism for Ebola testing — the FlashDetect rapid testing line and the fully automated Flash10, Robo and Nano molecular robot family, as well as digital PCR platforms, holding around 95 patents according to industry sources.
Its applications cover infectious diseases, personalised medicine and cancer screening, with solutions deployable in hospitals, disease control centres and low-resource settings. For distributors of rapid molecular diagnostics, Coyote offers a Chinese manufacturer with its own direct PCR technology and a complete chain of R&D, production, sales and testing services.